Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis-Reference-Cited by-同舟云学术

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis

Published:2012-05 Issue:5 Volume:56 Page:1112-1120
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Memon Khairuddin,Kulik Laura,Lewandowski Robert J.,Wang Edward,Ryu Robert K.,Riaz Ahsun,Nikolaidis Paul,Miller Frank H.,Yaghmai Vahid,Baker Talia,Abecassis Michael,Benson Al B.,Mulcahy Mary F.,Omary Reed A.,Salem Riad

Funder

NIH

Publisher

Elsevier BV

Subject

Hepatology

Reference47 articles.

1. Hepatocellular carcinoma and hepatitis C in the United States;El-Serag;Hepatology,2002

2. Hepatocellular carcinoma incidence, mortality, and survival benefits in the United States from 1975 to 2005;Alterkruse;J Clin Oncol,2009

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

5. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization;Maddala;Liver Transpl,2004

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum CYFRA 21-1 and CK19-2G2 as Predictive Biomarkers of Response to Transarterial Chemoembolization in Hepatitis C–related Hepatocellular Carcinoma Among Egyptians: A Prospective Study;Journal of Clinical and Experimental Hepatology;2025-01

2. Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma;Romanian Journal of Internal Medicine;2024-08-29

3. An efficient DNAzyme-locked leakless enzyme-free amplification system for alpha-foetoprotein detection in liver cancer and breast cancer;Microchimica Acta;2024-07-25

4. Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study;Frontiers in Immunology;2024-02-16

5. Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy;Journal for ImmunoTherapy of Cancer;2024-01